Mark Coleman - 23 Feb 2026 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Reporting relationship: Director
Issuer ticker: AXSM
Reported as of: 23 Feb 2026
Net transaction value: +$30,938
SEC form: 4
Accepted by SEC: 25 Feb 2026, 19:00:03 UTC
Prior SEC filing: 23 Feb 2026
Next SEC filing: 27 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Nick Pizzie, Attorney-in-Fact

Key filing fact

Mark Coleman filed Form 4 for Axsome Therapeutics, Inc. (AXSM) on 25 Feb 2026.

Key facts

This page summarizes Mark Coleman's Form 4 filing for Axsome Therapeutics, Inc. (AXSM).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 25 Feb 2026, 19:00.

Change

Previous filing in this sequence was filed on 23 Feb 2026.
Current net transaction value: +$30,938.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001658379 Primary reporting owner

Coleman Mark

Relationship: Director
Address: C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Signature: /s/ Nick Pizzie, Attorney-in-Fact
Signature date: 25 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXSM transaction

Common Stock

Options Exercise

Transaction value: $30,938
Shares: +6,250
Change %: +9.5%
Price: $4.95
Shares after: 72,140
Date: 23 Feb 2026
Ownership: Direct
Footnotes: F1

AXSM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 403,856
Date: 23 Feb 2026
Ownership: See Footnote
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXSM transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -6,250
Change %: -45%
Price: $0.000000
Shares after: 7,721
Date: 23 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,250
Exercise price: $4.95
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares.

Footnote F2

Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.